Last Updated: 14 Sep 2024
Executive Summary
CNO Financial Group Inc. (CNO) is a leading provider of health insurance, annuities, and life insurance products in the United States. The company has a strong financial position, with a market capitalization of $3.49 billion and an EBITDA of $1.09 billion. CNO's trailing PE ratio of 8.58 suggests that it is undervalued compared to its peers. The company's dividend yield of 0.0196% is also attractive.
Company Overview
CNO Financial Group Inc. was founded in 1985 and is headquartered in Carmel, Indiana. The company has a long history of providing high-quality insurance products to the middle-income and senior markets. CNO's products are distributed through a network of independent agents and brokers.
Fundamental Analysis
CNO's financial performance has been strong in recent years. The company's revenue has grown at a CAGR of 4.2% over the past five years. CNO's net income has also grown at a CAGR of 6.5% over the same period. The company's profit margin is 9.96%, which is above the industry average.
CNO's balance sheet is also strong. The company has a debt-to-equity ratio of 0.36, which is below the industry average. CNO also has a strong cash position, with $1.2 billion in cash and equivalents on hand.
Technical Analysis
CNO's stock price has been trading in a range between $21.79 and $35.28 over the past 52 weeks. The stock is currently trading at $33.05, which is near the middle of its 52-week range. The stock's 50-day moving average is $31.74, and its 200-day moving average is $28.3.
Short Term Outlook
CNO's stock is expected to continue to trade in a range in the short term. The stock's technical indicators are neutral, and there are no major catalysts on the horizon.
Long Term Outlook
CNO's long-term outlook is positive. The company's strong financial position and its focus on the growing middle-income and senior markets position it well for continued growth.
Analyst Recommendations
The majority of analysts have a "Hold" rating on CNO's stock. However, there are two analysts who have a "Buy" rating on the stock and one analyst who has a "Strong Buy" rating. The average analyst target price for CNO's stock is $33.6.
